Condition: Asthma
Interventions: Biological: Benralizumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified June 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Biological: Benralizumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified June 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Impacts of coexisting bronchial asthma on severe exacerbations in mild | COPD
Dove Medical Press Backround: Acute exacerbations are major drivers of COPD deterioration. However, limited data are available for the prevalence of severe exacerbations and impact of asthma on severe exacerbations, especially in patients with mild-to-moderate COPD. |
View full post on asthma – Google News
Condition: Mild Asthma
Interventions: Drug: 90 mcg Reference Product; Drug: 180 mcg Reference Product; Drug: 90 mcg Test Product; Drug: Placebo
Sponsor: Cipla Ltd.
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Drug: MEDI9929 (AMG 157)
Sponsors: MedImmune LLC; Amgen
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Atopic Asthma
Interventions: Drug: ibuprofen; Drug: Placebo
Sponsor: University of Saskatchewan
Recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Pulmonary Disease, Chronic Obstructive; Overweight
Interventions: Dietary Supplement: Resveratrol; Dietary Supplement: Placebo
Sponsors: Maastricht University Medical Center; The Netherlands Asthma Foundation; DSM Nutritional Products, Inc.
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Healthy; Asthma
Interventions: Drug: JNJ-43260295; Drug: Placebo; Other: Nasal Allergen Challenge
Sponsor: Janssen Research & Development, LLC
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: BHT 0.1%; Drug: BHT 0.5%; Drug: Placebo for RMT-B; Drug: Placebo for HFA-MDI
Sponsor: Boehringer Ingelheim
Completed – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Mild weather good news for asthma sufferers
Toledo Blade The next few days should be easier on asthma sufferers and others with respiratory distress because mild weather and gentle wind patterns will help keep smog levels down. Toledo's division of environmental services is predicting satisfactory air … |
View full post on asthma – Google News